PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10632359-1	1999	We previously found that 2-chloroethyl-3-sarcosin-amide-1-nitrosourea (SarCNU), a new chloroethylnitrosourea analogue presently in phase I clinical trials, is a selective cytotoxin that enters cells via the extraneuronal transporter for monoamine transmitters (EMT).	2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide	25-69	IL2 inducible T cell kinase	Homo sapiens	261-264	
10632359-1	1999	We previously found that 2-chloroethyl-3-sarcosin-amide-1-nitrosourea (SarCNU), a new chloroethylnitrosourea analogue presently in phase I clinical trials, is a selective cytotoxin that enters cells via the extraneuronal transporter for monoamine transmitters (EMT).	2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide	71-77	IL2 inducible T cell kinase	Homo sapiens	261-264